Glomerulonephritis is a kidney disease characterized by inflammation of the glomeruli (small filtering units) in the kidneys. It can occur as a result of various causes, including infectious and non-infectious factors. Glomerulonephritis can be both acute and chronic, which leads to different clinical presentation and prognosis. Pathophysiologically, the disease can be associated with autoimmune processes, infections, or consequences of systemic diseases. As a result of the inflammatory process, damage to the glomerular structure occurs, which affects blood filtration, causes proteinuria, hematuria, and can lead to the development of chronic renal failure.
History of the disease and interesting historical facts
Glomerulonephritis has been known to mankind since ancient times. The first mentions of kidney disease can be found in medical texts of Ancient Egypt and Greece. Hippocrates described the symptoms of kidney disease, which were later attributed to glomerulonephritis. However, the scientific description of the disease began only in the 19th century, when the German pathologist Eduard Hammer first identified glomerulonephritis as an independent disease in 1842. Since then, researchers have focused on studying its etiology, pathogenesis and clinical manifestations. In the 20th century, significant advances were made in the field of diagnosis and treatment of this disease, which improved the prognosis for patients.
Epidemiology
According to the World Health Organization, the incidence of glomerulonephritis varies by region and age. The overall incidence is 1 to 25 cases per 100,000 population per year, with a higher incidence in children and young adults. In different countries, mortality from glomerulonephritis ranges from 0.5% to 2% of the total number of kidney diseases. Studies show that the greatest predisposition to the disease is observed in people with hereditary syndromes such as Alport syndrome and phenylketonuria.
Genetic predisposition to this disease
Genetic predisposition plays an important role in the development of glomerulonephritis. Studies show that mutations in some genes can increase the risk of developing the disease. Among the genes involved, a subgroup can be distinguished that affects the immune response and inflammatory processes. In particular, genes responsible for coding complement proteins (for example, C3, C5) were associated with the development of glomerulonephritis. Genetic studies also indicate an association with HLA genes, which emphasizes the immunological nature of the disease. Disturbances in the expression of these genes can lead to autoimmune inflammation, which contributes to the development of glomerulonephritis.
Risk factors for the development of this disease
Risk factors that contribute to the development of glomerulonephritis include both external and internal conditions. The main physical factors include:
- Chronic infections such as streptococcal infection;
- Immune disorders including systemic lupus erythematosus;
- Toxic substances, including drugs and alkaloids;
- Occupations with high levels of exposure to chemicals, such as working in the chemical industry.
Chemical factors may also be associated with long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) and certain antibiotics. It is important to note that the tendency to develop the disease can be inherited, making genetic predisposition an important factor.
Diagnosis of this disease
Diagnosis of glomerulonephritis is based on a combination of clinical symptoms and laboratory data. The main symptoms include:
- Proteinuria (detection of protein in urine);
- Hematuria (detection of blood cells in the urine);
- Swelling (especially in the face and extremities);
- Hypertension (high blood pressure);
- Decreased urine production.
Laboratory tests include urinalysis, serum biochemistry, and antibody testing against major pathogens. Radiologic tests such as renal ultrasound may help visualize structural changes. Differential diagnosis is important to exclude other disorders such as diabetic nephropathy and chronic pyelonephritis.
Treatment
Treatment of glomerulonephritis includes conservative, pharmacological and, in some cases, surgical methods. The main principles of treatment are to control the inflammatory process and correct the disorders associated with the disease.
- General treatment includes a low-protein diet, salt restriction and blood pressure control;
- Pharmacological treatment: administration of corticosteroids, immunosuppressants, and angiotensin-converting enzyme (ACE) to control hypertension;
- Surgical treatment: may be necessary in cases of severe nephrotic syndrome or in patients with end-stage renal failure - for example, in kidney transplantation;
- Other treatments: plasmapheresis to remove atypical antibodies and other pathogenic factors.
List of medications used to treat this disease
Among the drugs most frequently used in the treatment of glomerulonephritis, the following can be distinguished:
- Prednisolone;
- Azathioprine;
- Cyclophosphamide;
- Losartan;
- Atenolol.
It is also important to consider possible side effects and regularly monitor renal function in patients receiving therapy.
Disease monitoring
Monitoring of glomerulonephritis involves monitoring clinical symptoms, laboratory parameters, and kidney function. This includes regular visits to the doctor, urine and blood tests, and imaging studies. The prognosis of the disease may vary depending on its etiology, the presence of complications, and the adequacy of treatment. Complications include chronic renal failure, hypertension, and cardiovascular disorders.
Age-related features of the disease
Glomerulonephritis can manifest itself in different age groups. In children, the disease is often associated with post-streptococcal infection, while in adolescents and young adults, more acute manifestations are observed, requiring intensive treatment. In older people, glomerulonephritis can occur in more erased forms, which makes its diagnosis more difficult. It is important to adhere to an individual approach to treatment depending on the patient's age.
Questions and Answers
- What is glomerulonephritis? It is a kidney disease characterized by inflammation of the glomeruli, which can lead to impaired renal function, proteinuria and hematuria.
- What are the main symptoms of glomerulonephritis? The main symptoms include swelling, increased blood pressure, changes in urine color and decreased urine volume.
- What treatments are used for glomerulonephritis? Treatment can be conservative (lifestyle and diet correction), pharmacological (corticosteroids, immunosuppressants) and surgical (in some cases).
- What is the relationship between glomerulonephritis and infections? Infections such as streptococcal infections can trigger inflammation in the kidneys, leading to glomerulonephritis.
- How can glomerulonephritis be prevented? Preventing infection, maintaining good hygiene, and controlling chronic diseases can reduce the risk of developing glomerulonephritis.
Advice from Dr. Oleg Korzhikov
With glomerulonephritis, it is important to remember to monitor your own condition. Strive for regular examinations and monitor your health indicators. If you have doubts about the treatment or symptoms, do not hesitate to contact a doctor. It is also recommended to follow a balanced diet, avoid stress and lack of physical activity. Consider your individual predisposition and genetic factors, which will help you choose the right preventive measures.
